Tcr2 Therapeutics Overview

Tcr2 Therapeutics Operating Income

Operating Income for TCRR.

Quarterly Operating Income

$-41507000.00

↑ 42.13% YoY

As of Mar 31, 2023

Annual Operating Income (TTM)

$-165803000.00

↑ 54.5% YoY

Trailing 12 months ending Mar 31, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin